BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15096454)

  • 1. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.
    Lips DJ; Bueno OF; Wilkins BJ; Purcell NH; Kaiser RA; Lorenz JN; Voisin L; Saba-El-Leil MK; Meloche S; Pouysségur J; Pagès G; De Windt LJ; Doevendans PA; Molkentin JD
    Circulation; 2004 Apr; 109(16):1938-41. PubMed ID: 15096454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.
    Bueno OF; De Windt LJ; Tymitz KM; Witt SA; Kimball TR; Klevitsky R; Hewett TE; Jones SP; Lefer DJ; Peng CF; Kitsis RN; Molkentin JD
    EMBO J; 2000 Dec; 19(23):6341-50. PubMed ID: 11101507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
    Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    Das S; Tosaki A; Bagchi D; Maulik N; Das DK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
    Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
    Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
    Liang Q; Wiese RJ; Bueno OF; Dai YS; Markham BE; Molkentin JD
    Mol Cell Biol; 2001 Nov; 21(21):7460-9. PubMed ID: 11585926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator of G-protein signaling 5 protects cardiomyocytes against apoptosis during in vitro cardiac ischemia-reperfusion in mice by inhibiting both JNK1/2 and P38 signaling pathways.
    Wang Z; Huang H; He W; Kong B; Hu H; Fan Y; Liao J; Wang L; Mei Y; Liu W; Xiong X; Peng J; Xiao Y; Huang D; Quan D; Li Q; Xiong L; Zhong P; Wang G
    Biochem Biophys Res Commun; 2016 Apr; 473(2):551-7. PubMed ID: 27021681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.
    Ueyama T; Kawashima S; Sakoda T; Rikitake Y; Ishida T; Kawai M; Yamashita T; Ishido S; Hotta H; Yokoyama M
    J Mol Cell Cardiol; 2000 Jun; 32(6):947-60. PubMed ID: 10888249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning.
    Takeishi Y; Huang Q; Wang T; Glassman M; Yoshizumi M; Baines CP; Lee JD; Kawakatsu H; Che W; Lerner-Marmarosh N; Zhang C; Yan C; Ohta S; Walsh RA; Berk BC; Abe J
    J Mol Cell Cardiol; 2001 Nov; 33(11):1989-2005. PubMed ID: 11708843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.
    Sasaki T; Shishido T; Kadowaki S; Kitahara T; Suzuki S; Katoh S; Funayama A; Netsu S; Watanabe T; Goto K; Takeishi Y; Kubota I
    Heart Vessels; 2014 Jan; 29(1):110-8. PubMed ID: 23719772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Na+/H+ exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium.
    Moor AN; Gan XT; Karmazyn M; Fliegel L
    J Biol Chem; 2001 May; 276(19):16113-22. PubMed ID: 11279085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
    Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
    Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.
    Purcell NH; Wilkins BJ; York A; Saba-El-Leil MK; Meloche S; Robbins J; Molkentin JD
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14074-9. PubMed ID: 17709754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass.
    Talmor D; Applebaum A; Rudich A; Shapira Y; Tirosh A
    Circ Res; 2000 May; 86(9):1004-7. PubMed ID: 10807874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemic postconditioning protects hypertrophic myocardium by ERK1/2 signaling pathway: experiment with mice].
    Li XM; Ma YT; Yang YN; Zhang JF; Chen BD; Liu F; Huang Y; Han W; Gao XM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):846-50. PubMed ID: 19595127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.
    Bueno OF; Molkentin JD
    Circ Res; 2002 Nov; 91(9):776-81. PubMed ID: 12411391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.
    Kehat I; Davis J; Tiburcy M; Accornero F; Saba-El-Leil MK; Maillet M; York AJ; Lorenz JN; Zimmermann WH; Meloche S; Molkentin JD
    Circ Res; 2011 Jan; 108(2):176-83. PubMed ID: 21127295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.